Analysen zu Evonik AG
| 06.11.24 | Evonik Buy | Warburg Research | |
| 06.11.24 | Evonik Neutral | UBS AG | |
| 06.11.24 | Evonik Neutral | Goldman Sachs Group Inc. | |
| 06.11.24 | Evonik Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Evonik Hold | Jefferies & Company Inc. | |
| 17.10.24 | Evonik Buy | Warburg Research | |
| 14.10.24 | Evonik Buy | Deutsche Bank AG | |
| 14.10.24 | Evonik Neutral | UBS AG | |
| 11.10.24 | Evonik Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | Evonik Kaufen | DZ BANK | |
| 13.09.24 | Evonik Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.24 | Evonik Neutral | UBS AG | |
| 09.09.24 | Evonik Overweight | JP Morgan Chase & Co. | |
| 06.09.24 | Evonik Overweight | Barclays Capital | |
| 12.08.24 | Evonik Neutral | UBS AG | |
| 07.08.24 | Evonik Buy | Warburg Research | |
| 06.08.24 | Evonik Neutral | Goldman Sachs Group Inc. | |
| 06.08.24 | Evonik Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.08.24 | Evonik Hold | Jefferies & Company Inc. | |
| 01.08.24 | Evonik Overweight | JP Morgan Chase & Co. | |
| 01.08.24 | Evonik Buy | Warburg Research | |
| 01.08.24 | Evonik Neutral | Goldman Sachs Group Inc. | |
| 01.08.24 | Evonik Hold | Jefferies & Company Inc. | |
| 24.07.24 | Evonik Kaufen | DZ BANK | |
| 19.07.24 | Evonik Neutral | UBS AG | |
| 16.07.24 | Evonik Buy | Deutsche Bank AG | |
| 16.07.24 | Evonik Buy | Warburg Research | |
| 16.07.24 | Evonik Overweight | JP Morgan Chase & Co. | |
| 15.07.24 | Evonik Neutral | UBS AG | |
| 15.07.24 | Evonik Neutral | Goldman Sachs Group Inc. | |
| 15.07.24 | Evonik Neutral | UBS AG | |
| 15.07.24 | Evonik Hold | Jefferies & Company Inc. | |
| 11.07.24 | Evonik Overweight | JP Morgan Chase & Co. | |
| 09.07.24 | Evonik Buy | Warburg Research | |
| 08.07.24 | Evonik Neutral | UBS AG | |
| 05.07.24 | Evonik Buy | Deutsche Bank AG | |
| 01.07.24 | Evonik Neutral | Goldman Sachs Group Inc. | |
| 24.06.24 | Evonik Add | Baader Bank | |
| 31.05.24 | Evonik Hold | Jefferies & Company Inc. | |
| 24.05.24 | Evonik Buy | Warburg Research | |
| 17.05.24 | Evonik Buy | Deutsche Bank AG | |
| 10.05.24 | Evonik Kaufen | DZ BANK | |
| 10.05.24 | Evonik Neutral | Goldman Sachs Group Inc. | |
| 09.05.24 | Evonik Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.05.24 | Evonik Buy | Deutsche Bank AG | |
| 09.05.24 | Evonik Overweight | JP Morgan Chase & Co. | |
| 08.05.24 | Evonik Neutral | UBS AG | |
| 08.05.24 | Evonik Buy | Warburg Research | |
| 08.05.24 | Evonik Add | Baader Bank | |
| 08.05.24 | Evonik Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 12.02.26 | Adyen B.V. Parts Sociales Overweight | JP Morgan Chase & Co. | |
| 12.02.26 | Hermès Outperform | Bernstein Research | |
| 12.02.26 | AB InBev Outperform | Bernstein Research | |
| 12.02.26 | Heidelberg Materials Overweight | Barclays Capital | |
| 12.02.26 | KWS SAAT Add | Baader Bank | |
| 12.02.26 | McDonald's Overweight | JP Morgan Chase & Co. | |
| 12.02.26 | ams-OSRAM Underweight | JP Morgan Chase & Co. | |
| 12.02.26 | Siemens Sector Perform | RBC Capital Markets | |
| 12.02.26 | KWS SAAT Buy | Warburg Research | |
| 12.02.26 | Deutsche Börse Hold | Warburg Research | |
| 12.02.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 12.02.26 | Michelin Buy | Jefferies & Company Inc. | |
| 12.02.26 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 12.02.26 | Philips Buy | UBS AG | |
| 12.02.26 | SCHOTT Pharma Buy | UBS AG | |
| 12.02.26 | Michelin Buy | Deutsche Bank AG | |
| 12.02.26 | Carl Zeiss Meditec Neutral | UBS AG | |
| 12.02.26 | grenke Buy | Deutsche Bank AG | |
| 12.02.26 | Deutsche Telekom Buy | Deutsche Bank AG | |
| 12.02.26 | Novartis Buy | Deutsche Bank AG | |
| 12.02.26 | Deutsche Börse Neutral | UBS AG | |
| 12.02.26 | Bechtle Buy | UBS AG | |
| 12.02.26 | thyssenkrupp Underweight | Barclays Capital | |
| 12.02.26 | TotalEnergies Overweight | Barclays Capital | |
| 12.02.26 | Michelin Underweight | Barclays Capital | |
| 12.02.26 | ams-OSRAM Equal Weight | Barclays Capital | |
| 12.02.26 | Deutsche Börse Overweight | Barclays Capital | |
| 12.02.26 | EssilorLuxottica Overweight | Barclays Capital | |
| 12.02.26 | McDonald's Overweight | Barclays Capital | |
| 12.02.26 | Mercedes-Benz Group Neutral | UBS AG | |
| 12.02.26 | Befesa Buy | UBS AG | |
| 12.02.26 | Volvo AB Buy | UBS AG | |
| 12.02.26 | Unilever Sell | UBS AG | |
| 12.02.26 | flatexDEGIRO Buy | UBS AG | |
| 12.02.26 | Carl Zeiss Meditec Equal Weight | Barclays Capital | |
| 12.02.26 | Adyen B.V. Parts Sociales Overweight | Barclays Capital | |
| 12.02.26 | Deutsche Telekom Overweight | Barclays Capital | |
| 12.02.26 | Sanofi Equal Weight | Barclays Capital | |
| 12.02.26 | TotalEnergies Buy | UBS AG | |
| 12.02.26 | voestalpine kaufen | Deutsche Bank AG | |
| 12.02.26 | Siemens Buy | UBS AG | |
| 12.02.26 | Adyen B.V. Parts Sociales Buy | UBS AG | |
| 12.02.26 | RELX Buy | UBS AG | |
| 12.02.26 | Airbus Buy | UBS AG | |
| 12.02.26 | Hermès Neutral | UBS AG | |
| 12.02.26 | Gerresheimer Hold | Deutsche Bank AG | |
| 12.02.26 | SCHOTT Pharma Hold | Deutsche Bank AG | |
| 12.02.26 | AB InBev Buy | UBS AG | |
| 12.02.26 | BAT Underperform | RBC Capital Markets | |
| 12.02.26 | Hermès Outperform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.